Sherpa Venture Capital
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Sherpa Venture Capital Information
Geographic Data
Address: No. 8 Beichen East Road
City: Beijing
State: beijing municipality
Zip: 010 100000
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfolio sources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2021 | Visen Pharmaceuticals | Series B | 0 |
| 11/2021 | Sepax Technologies | Series D | 0 |
| 6/2022 | Raykol | Series A | 14.8M |
| 9/2022 | Neukio Biotherapeutics | Series A | 50M |
| 12/2021 | Starna Therapeutics | Angel Round | 10M |
| 11/2021 | Wuxi Biortus Biosciences | Series B | 31.3M |
| 5/2022 | Ketai Bio | Series A | 14.9M |
| 11/2021 | Singleron Biotechnologies | Series B | 0 |
| 3/2019 | Leto Laboratories | Series A | 3M |
| 3/2021 | EpimAb Biotherapeutics | Series C | 0 |
| 8/2020 | Zion Pharma | Series A | 20M |
| 9/2021 | Alamar Biosciences | Series B | 80M |
| 3/2022 | Yuesai Biotechnology | Seed Round | 0 |
| 7/2021 | Hongyun Biotech | Series B | 15.4M |
| 12/2019 | KeChow Pharma | Series C | 45M |
| 6/2022 | Changjin Biotechnology | Series A | 22M |
| 7/2021 | Bota Biosciences | Series B | 100M |
| 7/2021 | Zion Pharma | Series B | 40M |
| 12/2022 | Huihe Healthcare | Series C | - |
| 12/2019 | Nanovision Technology | Series B | 22.9M |
| 5/2021 | XISOFT | Series A | 15.7M |
| 6/2019 | Singleron Biotechnologies | Seed Round | 14.6M |
| 10/2016 | Wag | Series B | 15M |
| 1/2023 | BlissBio | Series B | 14.8M |
| 5/2022 | Starna Therapeutics | Series A | 0 |
| 5/2021 | Alebund Pharmaceuticals | Series B | 0 |
| 4/2022 | Shenji Bio | Series A | 47.1M |
| 6/2019 | EpimAb Biotherapeutics | Series B | 74M |
| 1/2019 | Immunochina | Series C | 20.6M |
| 7/2021 | Neukio Biotherapeutics | Angel Round | 40M |
| 11/2021 | BAKX Therapeutics | Series A | 25M |
| 9/2022 | Insight Lifetech | Series D | - |
| 8/2021 | CashBackMobileApp | Pre Seed Round | 475k |
| 9/2021 | Vision X | Series B | - |
| 9/2019 | GKHT Medical Technology | Series C | 154.5M |
| 12/2019 | Hui-Gene Therapeutics | Series A | 14.2M |
| 7/2021 | Jyss Bio | Series B | - |
| 7/2021 | PAQ Therapeutics | Series A | 0 |
| 3/2021 | Jianhai Technology | Series B | 23M |
| 7/2019 | Jianhai Technology | Series A | 14.6M |
| 2/2020 | Hongyun Biotech | Series A | 7.2M |
| 7/2019 | Joinhealth Technology | Series A | 14.6M |
| 5/2022 | Hui-Gene Therapeutics | Series C | - |
| 9/2020 | Bota Biosciences | Series A | 15M |
| 5/2021 | Appia Bio | Series A | 52M |
| 12/2014 | Mattermark | Series A | 0 |
| 12/2021 | Pilot Biotechnology | Series C | - |
| 7/2022 | ClinChoice昆翎 | Series E | 0 |
| 9/2021 | Alebund Pharmaceuticals | Series B | 0 |
| 6/2021 | HiFiBiO | Series D | 0 |
| 6/2018 | Hongyun Biotech | Angel Round | 3.1M |
| 5/2021 | MindRank AI | Seed Round | 7M |
| 4/2021 | Brattea | Series B | 20M |
| 4/2021 | EdiGene | Series B | 61.6M |
| 1/2019 | Yosemite Clinic | Series B | 14.9M |
| 9/2020 | Jianhai Technology | Series A | 8.8M |
| 5/2019 | New Horizon Health | Series C | 0 |
| 7/2021 | MAXVAX | Series A | - |
| 6/2022 | Yuanyin Bio | Series A | 0 |
| 12/2021 | MindRank AI | Series A | 19M |
| 11/2021 | Fuse Biotherapeutics | Seed | 9.5M |
| 3/2022 | UniXell | Seed Round | 0 |
| 7/2022 | ClinChoice昆翎 | Series E | 0 |
| 6/2022 | Yuanyin Bio | Series A | 0 |
| 6/2022 | Raykol | Series A | 0 |
| 5/2022 | Starna Therapeutics | Series A | 0 |
| 5/2022 | Hui-Gene Therapeutics | Series C | - |
| 4/2022 | Shenji Bio | Series A | 0 |
| 3/2022 | UniXell | Seed Round | 0 |
| 3/2022 | Yuesai Biotechnology | Seed Round | 0 |
| 12/2021 | Pilot Biotechnology | Series C | - |
| 12/2021 | MindRank AI | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
